Drug Shortage Report for FENTORA
Report ID | 142198 |
Drug Identification Number | 02408015 |
Brand name | FENTORA |
Common or Proper name | FENTORA 200MCG BUCCAL TAB PP 28 |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FENTANYL |
Strength(s) | 200MCG |
Dosage form(s) | TABLET (EFFERVESCENT) |
Route of administration | SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL |
Packaging size | 28 |
ATC code | N02AB |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-07-08 |
Estimated end date | 2021-10-31 |
Actual end date | 2021-10-13 |
Shortage status | Resolved |
Updated date | 2021-10-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-10-14 | French | Compare |
v8 | 2021-10-14 | English | Compare |
v7 | 2021-10-07 | French | Compare |
v6 | 2021-10-07 | English | Compare |
v5 | 2021-08-27 | French | Compare |
v4 | 2021-08-27 | English | Compare |
v3 | 2021-07-09 | English | Compare |
v2 | 2021-07-08 | French | Compare |
v1 | 2021-07-08 | English | Compare |
Showing 1 to 9 of 9